Notice of Charter Renewal, 47834-47835 [2016-17418]
Download as PDF
<![CDATA[
47834
Federal Register / Vol. 81, No. 141 / Friday, July 22, 2016 / Notices
Established
2016
quotas
(g)
Basic class
Proposed
revised 2016
quotas
(g)
Meperidine Intermediate-B .............................................................................................................................
Meperidine Intermediate-C .............................................................................................................................
Metazocine ......................................................................................................................................................
Methadone (for sale) ......................................................................................................................................
Methadone Intermediate .................................................................................................................................
Methamphetamine ..........................................................................................................................................
11
6
19
31,875,000
34,375,000
2,061,375
no
no
no
no
no
no
change.
change.
change.
change.
change.
change.
[1,250,000 grams of levo-desoxyephedrine for use in a non-controlled, non-prescription product; 750,000 grams for methamphetamine mostly for
conversion to a schedule III product; and 61,375 grams for methamphetamine (for sale)]
Methylphenidate ..............................................................................................................................................
Morphine (for conversion) ...............................................................................................................................
Morphine (for sale) .........................................................................................................................................
Nabilone ..........................................................................................................................................................
Noroxymorphone (for conversion) ..................................................................................................................
Noroxymorphone (for sale) .............................................................................................................................
Opium (powder) ..............................................................................................................................................
Opium (tincture) ..............................................................................................................................................
Oripavine .........................................................................................................................................................
Oxycodone (for conversion) ...........................................................................................................................
Oxycodone (for sale) ......................................................................................................................................
Oxymorphone (for conversion) .......................................................................................................................
Oxymorphone (for sale) ..................................................................................................................................
Pentobarbital ...................................................................................................................................................
Phenazocine ...................................................................................................................................................
Phencyclidine ..................................................................................................................................................
Phenmetrazine ................................................................................................................................................
Phenylacetone ................................................................................................................................................
Racemethorphan ............................................................................................................................................
Racemorphan .................................................................................................................................................
Remifentanil ....................................................................................................................................................
Secobarbital ....................................................................................................................................................
Sufentanil ........................................................................................................................................................
Tapentadol ......................................................................................................................................................
Thebaine .........................................................................................................................................................
96,750,000
91,250,000
62,500,000
18,750
17,500,000
1,475,000
112,500
687,500
30,000,000
6,250,000
139,150,000
29,000,000
7,750,000
38,125,000
6
50
3
50
3
3
3,750
215,003
6,255
25,500,000
125,000,000
84,375,000.
no change.
no change.
no change.
no change.
625,000.
no change.
375,000.
no change.
5,000,000.
no change.
25,000,000.
6,250,000.
no change.
no change.
no change.
no change.
no change.
5.
no change.
no change.
no change.
no change.
no change.
no change.
100,000
4,000,000
22,400,000
8,500,000
7,000
224,500,000
50,000.
no change.
15,000,000.
no change.
40.
200,000,000.
List I Chemicals
Ephedrine (for conversion) .............................................................................................................................
Ephedrine (for sale) ........................................................................................................................................
Phenylpropanolamine (for conversion) ...........................................................................................................
Phenylpropanolamine (for sale) ......................................................................................................................
Pseudoephedrine (for conversion) .................................................................................................................
Pseudoephedrine (for sale) ............................................................................................................................
The Acting Administrator further
proposes that aggregate production
quotas for all other schedule I and II
controlled substances included in 21
CFR 1308.11 and 1308.12 remain at
zero. In accordance with 21 CFR
1303.13 and 21 CFR 1315.13, upon
consideration of the relevant factors, the
Acting Administrator may adjust the
2016 aggregate production quotas and
assessment of annual needs as needed.
ehiers on DSK5VPTVN1PROD with NOTICES
Conclusion
Dated: July 14, 2016.
Chuck Rosenberg,
Acting Administrator.
[FR Doc. 2016–17371 Filed 7–21–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
After consideration of any comments
or objections, or after a hearing, if one
is held, the Acting Administrator will
issue and publish in the Federal
Register a final order establishing any
adjustment of 2016 aggregate production
quota for each basic class of controlled
substances in schedules I and II and
VerDate Sep<11>2014
established assessment of annual needs
for the list I chemicals ephedrine,
pseudoephedrine, and
phenylpropanolamine, 21 CFR
1303.13(c) and 1315.13(f).
15:19 Jul 21, 2016
Jkt 238001
Notice of Charter Renewal
Justice Department.
Notice of Charter Renewal of the
Executive Advisory Board of the
National Domestic Communications
Assistance Center.
AGENCY:
ACTION:
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
In accordance with the
provisions of the Federal Advisory
Committee Act, title 5, United States
Code, Appendix, and title 41 of the U.S.
Code of Federal Regulations, section
101–6.1015, notice is hereby given that
the Charter of the National Domestic
Communications Assistance Center
(NDCAC) Executive Advisory Board
(EAB) has been renewed. The Charter is
on file with the General Services
Administration. The Attorney General
determined that the NDCAC EAB is in
the public interest and is necessary in
connection with the performance of
duties of the United States Department
of Justice. These duties can best be
performed through the advice and
counsel of this group.
The purpose of the EAB is to provide
advice and recommendations to the
SUMMARY:
E:\FR\FM\22JYN1.SGM
22JYN1
Federal Register / Vol. 81, No. 141 / Friday, July 22, 2016 / Notices
Attorney General or designee, and to the
Director of the NDCAC that promote
public safety and national security by
advancing the NDCAC’s core functions:
law enforcement coordination with
respect to technical capabilities and
solutions, technology sharing, industry
relations, and implementation of the
Communications Assistance for Law
Enforcement Act (CALEA). The EAB
consists of 15 voting members from
Federal, State, local and tribal law
enforcement agencies. Additionally,
there are two non-voting members as
follows: a federally-employed attorney
assigned full time to the NDCAC to
serve as a legal advisor to the EAB, and
the DOJ Chief Privacy Officer or
designee to ensure that privacy and civil
rights and civil liberties issues are fully
considered in the EAB’s
recommendations. The EAB is
composed of eight State, local, and/or
tribal representatives and seven federal
representatives.
The EAB functions solely as an
advisory body in compliance with the
provisions of the Federal Advisory
Committee Act. The Charter has been
filed in accordance with the provisions
of the Act.
Alice Bardney-Boose,
Designated Federal Officer, National
Domestic Communication Assistance Center,
Executive Advisory Board.
[FR Doc. 2016–17418 Filed 7–21–16; 8:45 am]
BILLING CODE 4410–02–P
DEPARTMENT OF JUSTICE
ehiers on DSK5VPTVN1PROD with NOTICES
Notice of Lodging of Consent Decree
Under the Clean Air Act
On July 18, 2016, the Department of
Justice lodged a proposed Consent
Decree with the United States District
Court for the Western District of Texas
in United States, et al. v Tesoro Refining
& Marketing Co. LLC et al. Civil Action
No. SA–16–cv–00722.
The Consent Decree settles claims
brought by the United States, states of
Alaska and Hawaii, and the Northwest
Clean Air Agency against Tesoro
Refining & Marketing Co. LLC, Tesoro
Alaska Co. LLC, Tesoro Logistics L.P.,
and Par Hawaii Refining, LLC for
violations of the Clean Air Act, federal
regulations promulgated thereunder,
and various state regulations and
permits at six petroleum refineries
located in Kenai, Alaska; Martinez,
California; Kapolei, Hawaii; Mandan,
North Dakota; Salt Lake City, Utah; and
Anacortes, Washington. Under the
Consent Decree, Defendants will
undertake extensive measures to correct
the alleged violations, pay a civil
VerDate Sep<11>2014
15:19 Jul 21, 2016
Jkt 238001
penalty of $10,450 to the United States
and state co-plaintiffs, and perform
three projects to mitigate excess
emissions associated with the
violations.
The publication of this notice opens
a period for public comment on the
proposed Consent Decree. Comments
should be addressed to the Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States et al. v. Tesoro
Refining & Marketing Co. LLC et al., D.J.
Ref. No. 90–5–2–1–09512/1. All
comments must be submitted no later
than thirty (30) days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD,
P.O. Box 7611,
Washington, DC 20044–7611.
By mail .........
During the public comment period,
the Consent Decree may be examined
and downloaded at this Justice
Department Web site: https://
www.justice.gov/enrd/consent-decrees.
We will provide a paper copy of the
Consent Decree upon written request
and payment of reproduction costs.
Please mail your request and payment
to: Consent Decree Library, U.S. DOJ—
ENRD, P.O. Box 7611, Washington, DC
20044–7611.
Please enclose a check or money order
for $59.75 (25 cents per page
reproduction cost) payable to the United
States Treasury.
Jeffrey Sands,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2016–17393 Filed 7–21–16; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Office of Justice Programs
[OJP (OJJDP) Docket No. 1718]
Webinar Meeting of the Federal
Advisory Committee on Juvenile
Justice
Office of Juvenile Justice and
Delinquency Prevention, Justice.
ACTION: Notice of webinar meeting.
AGENCY:
The Office of Juvenile Justice
and Delinquency Prevention (OJJDP) has
scheduled a webinar meeting of the
SUMMARY:
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
47835
Federal Advisory Committee on
Juvenile Justice (FACJJ).
DATES: The webinar meeting will take
place online on Tuesday, August 2,
2016, at 1:00 p.m. ET.
FOR FURTHER INFORMATION CONTACT: Jeff
Slowikowski, Designated Federal
Official, OJJDP, Jeff.Slowikowski@
usdoj.gov or (202) 616–3646. [This is not
a toll-free number.]
SUPPLEMENTARY INFORMATION: FACJJ,
established pursuant to Section 3(2)A of
the Federal Advisory Committee Act (5
U.S.C. App.2), will meet to carry out its
advisory functions under Section
223(f)(2)(C–E) of the Juvenile Justice and
Delinquency Prevention Act of 2002.
The FACJJ is composed of
representatives from the states and
territories. FACJJ member duties
include: Reviewing Federal policies
regarding juvenile justice and
delinquency prevention; advising the
OJJDP Administrator with respect to
particular functions and aspects of
OJJDP; and advising the President and
Congress with regard to State
perspectives on the operation of OJJDP
and Federal legislation pertaining to
juvenile justice and delinquency
prevention. More information on the
FACJJ may be found at www.facjj.org.
Meeting Agenda: The proposed
agenda includes: (a) Opening
Introductions, and Webinar Logistics;
(b) Remarks of Robert L. Listenbee,
Administrator, OJJDP; (c) FACJJ
Subcommittee Reports (Legislation;
Expungement/Sealing of Juvenile Court
Records; Research/Publications; LGBT);
(d) FACJJ Administrative Business; and
(e) Summary, Next Steps, and Meeting
Adjournment.
To participate in or view the webinar
meeting, FACJJ members and the public
must pre-register online. Members and
interested persons must link to the
webinar registration portal through
www.facjj.org, no later than Wednesday,
July 27, 2016. Upon registration,
information will be sent to you at the
email address you provide to enable you
to connect to the webinar. Should
problems arise with webinar
registration, please call Callie Long
Murray at 571–308–6617. [This is not a
toll-free telephone number.] Note:
Members of the public will be able to
listen to and view the webinar as
observers, but will not be able to
participate actively in the webinar.
An on-site room is available for
members of the public interested in
viewing the webinar in person. If
members of the public wish to view the
webinar in person, they must notify
Melissa Kanaya by email message at
E:\FR\FM\22JYN1.SGM
22JYN1
]]>Agencies
[Federal Register Volume 81, Number 141 (Friday, July 22, 2016)]
[Notices]
[Pages 47834-47835]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-17418]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Notice of Charter Renewal
AGENCY: Justice Department.
ACTION: Notice of Charter Renewal of the Executive Advisory Board of
the National Domestic Communications Assistance Center.
-----------------------------------------------------------------------
SUMMARY: In accordance with the provisions of the Federal Advisory
Committee Act, title 5, United States Code, Appendix, and title 41 of
the U.S. Code of Federal Regulations, section 101-6.1015, notice is
hereby given that the Charter of the National Domestic Communications
Assistance Center (NDCAC) Executive Advisory Board (EAB) has been
renewed. The Charter is on file with the General Services
Administration. The Attorney General determined that the NDCAC EAB is
in the public interest and is necessary in connection with the
performance of duties of the United States Department of Justice. These
duties can best be performed through the advice and counsel of this
group.
The purpose of the EAB is to provide advice and recommendations to
the
[[Page 47835]]
Attorney General or designee, and to the Director of the NDCAC that
promote public safety and national security by advancing the NDCAC's
core functions: law enforcement coordination with respect to technical
capabilities and solutions, technology sharing, industry relations, and
implementation of the Communications Assistance for Law Enforcement Act
(CALEA). The EAB consists of 15 voting members from Federal, State,
local and tribal law enforcement agencies. Additionally, there are two
non-voting members as follows: a federally-employed attorney assigned
full time to the NDCAC to serve as a legal advisor to the EAB, and the
DOJ Chief Privacy Officer or designee to ensure that privacy and civil
rights and civil liberties issues are fully considered in the EAB's
recommendations. The EAB is composed of eight State, local, and/or
tribal representatives and seven federal representatives.
The EAB functions solely as an advisory body in compliance with the
provisions of the Federal Advisory Committee Act. The Charter has been
filed in accordance with the provisions of the Act.
Alice Bardney-Boose,
Designated Federal Officer, National Domestic Communication Assistance
Center, Executive Advisory Board.
[FR Doc. 2016-17418 Filed 7-21-16; 8:45 am]
BILLING CODE 4410-02-P
